Literature DB >> 5688752

Clinical evaluation of possible etiologic factors in multiple sclerosis.

M Alter, J Speer.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5688752     DOI: 10.1212/wnl.18.2.109

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

2.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

3.  Risk of multiple sclerosis after head injury: record linkage study.

Authors:  M J Goldacre; J D Abisgold; D G R Yeates; V Seagroatt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 4.  The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature.

Authors:  R L Rabin; A I Levinson
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

Review 5.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Multiple sclerosis in Australia: socioeconomic factors.

Authors:  S R Hammond; J G McLeod; P Macaskill; D R English
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

Review 7.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682

Review 8.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.